{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:46:32Z","timestamp":1740138392999,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:00:00Z","timestamp":1616716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s12020-021-02700-6","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T05:21:20Z","timestamp":1616736080000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reduced fibroblast growth factor 21 and \u03b2-Klotho secretion in untreated congenital isolated GH deficiency"],"prefix":"10.1007","volume":"73","author":[{"given":"Al\u00e9cia A.","family":"Oliveira-Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-2244","authenticated-orcid":false,"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana C.","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica C.","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviane C.","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela A.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla R. P.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia S.","family":"Barros-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindi G.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayra P.","family":"Damascena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elenilde G.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enaldo V.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J. A.","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel H.","family":"Aguiar-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,26]]},"reference":[{"key":"2700_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"M Kuro-o","year":"2019","unstructured":"M. Kuro-o, The Klotho proteins in health and disease. Nat. Rev. Nephrol. 15, 27\u201344 (2019)","journal-title":"Nat. Rev. Nephrol."},{"key":"2700_CR2","doi-asserted-by":"publisher","first-page":"E292","DOI":"10.1152\/ajpendo.00101.2017","volume":"313","author":"T Xie","year":"2017","unstructured":"T. Xie, P.S. Leung, Fibroblast growth factor 21: a regulator of metabolic disease and health span. Am. J. Physiol. Endocrinol. Metab. 313, E292\u2013E302 (2017). https:\/\/doi.org\/10.1152\/ajpendo.00101.2017","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2700_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"M.C. Hu, K. Shiizaki, M. Kuro-o, O.W. Moe, Fibroblast growth factor 23 and klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev. Physiol. 75, 503\u2013533 (2013)","journal-title":"Annu Rev. Physiol."},{"key":"2700_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/dmrr.1177","volume":"27","author":"FL Mashili","year":"2011","unstructured":"F.L. Mashili, R.L. Austin, A.S. Deshmukh, T. Fritz, K. Caidahl, K. Bergdahl, J.R. Zierath, A.V. Chibalin, D.E. Moller, A. Kharitonenkov, A. Krook, Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res Rev. 27, 286\u2013297 (2011)","journal-title":"Diabetes Metab. Res Rev."},{"issue":"2","key":"2700_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1210\/er.2018-00216","volume":"40","author":"MH Aguiar-Oliveira","year":"2019","unstructured":"M.H. Aguiar-Oliveira, A. Bartke, Growth hormone deficiency: health and longevity. Endocr. Rev. 40(2), 575\u2013601 (2019)","journal-title":"Endocr. Rev."},{"key":"2700_CR6","doi-asserted-by":"publisher","unstructured":"M.H Aguiar-Oliveira, R. Salvatori, Disruption of the GHRH receptor and its impact on children and adults: the Itabaianinha syndrome. Rev. Endocr. Metab. Disord. (2020). https:\/\/doi.org\/10.1007\/s11154-020-09591-4","DOI":"10.1007\/s11154-020-09591-4"},{"issue":"5","key":"2700_CR7","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2337\/db07-1476","volume":"57","author":"X Zhang","year":"2008","unstructured":"X. Zhang, D.C.Y. Yeung, M. Karpisek, D. Stejskal, Z.-G. Zhou, F. Liu, R.L.C. Wong, W.-S. Chow, A.W.K. Tso, K.S.L. Lam, A. Xu, Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 57(5), 1246\u20131253 (2008)","journal-title":"Diabetes"},{"issue":"3","key":"2700_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","volume":"71","author":"M Mraz","year":"2009","unstructured":"M. Mraz, M. Bartlova, Z. Lacinova, D. Michalsky, M. Kasalicky, D. Haluzikova, M. Matoulek, I. Dostalova, V. Humenanska, M. Haluzik, Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin. Endocrinol. 71(3), 369\u2013375 (2009)","journal-title":"Clin. Endocrinol."},{"key":"2700_CR9","doi-asserted-by":"publisher","unstructured":"Z. Lin, Z. Wu, X. Yin, Y. Liu, X. Yan, S. Lin, J. Xiao, X. Wang, W. Feng, X. Li, Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile. Plos ONE. (2010). https:\/\/doi.org\/10.1371\/journal.pone.0015534","DOI":"10.1371\/journal.pone.0015534"},{"key":"2700_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1365-2362.2010.02338.x","volume":"40","author":"Y Yilmaz","year":"2010","unstructured":"Y. Yilmaz, F. Eren, O. Yonal, R. Kurt, B. Aktas, C.A. Celikel, O. Ozdogan, N. Imeryuz, C. Kalayci, E. Avsar, Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease. Eur. J. Clin. Invest 40, 887\u2013892 (2010)","journal-title":"Eur. J. Clin. Invest"},{"issue":"1","key":"2700_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","volume":"8","author":"T Inagaki","year":"2008","unstructured":"T. Inagaki, V.Y. Lin, R. Goetz, M. Mohammadi, D.J. Mangelsdorf, S.A. Kliewer, Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 8(1), 77\u201383 (2008)","journal-title":"Cell Metab."},{"key":"2700_CR12","doi-asserted-by":"publisher","unstructured":"C.M. Hill, E. Qualls-Creekmore, H.-R. Berthoud, P. Soto, S. Yu, D.H. McDougal, H. M\u00fcnzberg, C.D. Morrison, FGF21 and the physiological regulation of macronutrient preference. Endocrinology. 161(3) (2020). https:\/\/doi.org\/10.1210\/endocr\/bqaa019","DOI":"10.1210\/endocr\/bqaa019"},{"issue":"10","key":"2700_CR13","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1210\/jc.2017-01257","volume":"102","author":"RJ Samms","year":"2017","unstructured":"R.J. Samms, J.E. Lewis, L. Norton, F.B. Stephens, C.J. Gaffney, T. Butterfield, D.P. Smith, C.C. Cheng, J.W. Perfield, A.C. Adams, F.J.P. Ebling, K. Tsintzas, FGF21 is an insulin-dependent postprandial hormone in adult humans. J. Clin. Endocrinol. Metab. 102(10), 3806\u20133813 (2017)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2700_CR14","first-page":"917","volume":"84","author":"R Salvatori","year":"1999","unstructured":"R. Salvatori, C.Y. Hayashida, M.H. Aguiar-Oliveira, J.A. Phillips, A.H.O. Souza, R.G. Gondo, S.P.A. Toledo, M.M. Concei\u00e7\u00e3o, M. Prince, H.G. Maheshwari, G. Baumann, M.A. Levine, Familial Dwarfism due to a novel mutation of the Growth hormone-releasing hormone receptor gene. J. Clin. Endocrinol. Metab. 84(3), 917\u2013923 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2700_CR15","first-page":"4118","volume":"84","author":"MH Aguiar-Oliveira","year":"1999","unstructured":"M.H. Aguiar-Oliveira, M.S. Gill, S.E.A. Barretto, M.R.S. Alc\u00e2ntara, F. Miraki-Moud, C.A. Menezes, A.H.O. Souza, C.E. Martinelli, F.A. Pereira, R. Salvatori, M.A. Levine, S.M. Shalet, C. Camacho-Hubner, P.E: Clayton, Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J. Clin. Endocrinol. Metab. 84(11), 4118\u20134126 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2700_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1210\/jc.2011-2590","volume":"97","author":"CRP Oliveira","year":"2012","unstructured":"C.R.P. Oliveira, R. Salvatori, J.A.S. Barreto-Filho, I.E.S. Rocha, A. Mari, R.M.C. Pereira, V.C. Campos, M. Menezes, E. Gomes, R.A. Meneguz-Moreno, V.P. Ara\u00fajo, N.T.F. Leite, A.C. Nascimento-Junior, M.I.T. Farias, T.A.R. Viscente, R.D.C. Ara\u00fajo, E.V. Melo, M.H. Aguiar-Oliveira, Insulin sensitivity and \u03b2-cell function in adults with lifetime, untreated isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 97(3), 1013\u20131019 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2700_CR17","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1210\/jc.2005-2571","volume":"91","author":"JLM Oliveira","year":"2006","unstructured":"J.L.M. Oliveira, C. Marques-Santos, J.A. Barreto-Filho, R.X. Filho, A.V.O. Britto, A.H.O. Souza, C.M. Prado, C.R.P. Oliveira, R.M.C. Pereira, T.A.R. Vicente, C.T. Farias, M.H. Aguiar-Oliveira, R. Salvatori, Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation. J. Clin. Endocrinol. Metab. 91(6), 2093\u20132099 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2700_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1210\/jc.2009-1879","volume":"95","author":"MH Aguiar-Oliveira","year":"2010","unstructured":"M.H. Aguiar-Oliveira, F.T. Oliveira, R.M.C. Pereira, C.R.P. Oliveira, A. Blackford, E.H.O. Valen\u00e7a, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Ara\u00fajo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C.R. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95(2), 714\u2013721 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"2700_CR19","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1210\/jc.2019-00094","volume":"104","author":"AA Oliveira-Santos","year":"2019","unstructured":"A.A. Oliveira-Santos, R. Salvatori, M.C. Nogueira, A.C. Bueno, C.S. Barros-Oliveira, \u00c2.C.G.B. Leal, C.G. Marinho, N.P. Damascena, D.A. Oliveira, M.A. Melo, C.R.P. Oliveira, F.O. Costa, J.S.S. Santos, P.F.C. Santos, V.C. Campos, E.G. Santos, E.V. Melo, M.L.A. Barbosa, I.E.S. Rocha, M. Castro, M.H. Aguiar-Oliveira, Enteroendocrine connections in congenital isolated GH deficiency due to a GHRH receptor gene mutation. J. Clin. Endocrinol. Metab. 104(7), 2777\u20132784 (2019)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2700_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3109\/09513590.2010.487587","volume":"26","author":"S Gorar","year":"2010","unstructured":"S. Gorar, C. Culha, Z.A. Uc, F.D. Dellal, R. Serter, S. Aral, Y. Aral, Serum fibroblast growth factor 21 levels in polycystic ovary syndrome. Gynecol. Endocrinol. 26(11), 819\u2013826 (2010)","journal-title":"Gynecol. Endocrinol."},{"key":"2700_CR21","doi-asserted-by":"publisher","first-page":"415","DOI":"10.33549\/physiolres.931801","volume":"59","author":"V \u010eurovcov\u00e1","year":"2010","unstructured":"V. \u010eurovcov\u00e1, J. Marek, V. H\u00e1na, M. Matoulek, V. Zik\u00e1n, D. Haluz\u00edkov\u00e1, P. Kav\u00e1lkov\u00e1, Z. Lacinov\u00e1, M. Kr\u0161ek, M. Haluz\u00edk, Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing\u2019s syndrome. Physiol. Res 59, 415\u2013422 (2010)","journal-title":"Physiol. Res"},{"issue":"11","key":"2700_CR22","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2337\/db10-0193","volume":"59","author":"FM Fisher","year":"2010","unstructured":"F.M. Fisher, P.C. Chui, P.J. Antonellis, H.A. Bina, A. Kharitonenkov, J.S. Flier, E. Maratos-Flier, Obesity is a fibroblast growth factor 21 (FGF21)-resistant state. Diabetes 59(11), 2781\u20132789 (2010)","journal-title":"Diabetes"},{"issue":"11","key":"2700_CR23","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.2337\/db13-0645","volume":"62","author":"WY So","year":"2013","unstructured":"W.Y. So, Q. Cheng, L. Chen, C. Evans-Molina, A. Xu, K.S.L. Lam, P.S. Leung, High glucose represses \u03b2-klotho expression and impairs fibroblast growth factor 21 action in mouse pancreatic islets: involvement of peroxisome proliferator-activated receptor \u03b3 signaling. Diabetes 62(11), 3751\u20133759 (2013)","journal-title":"Diabetes"},{"issue":"3","key":"2700_CR24","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1210\/jc.2004-0545","volume":"90","author":"M Gola","year":"2005","unstructured":"M. Gola, S. Bonadonna, M. Doga, Giustina.: Growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90(3), 1864\u20131870 (2005)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2700_CR25","doi-asserted-by":"publisher","unstructured":"I.P. Biscotto, V.A.C Hong, R.L. Batista, B.B. Mendonca, I.J.P. Arnhold, L.A. Bortolotto, L.R.S. Carvalho, Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood. Pituitary. (2020). https:\/\/doi.org\/10.1007\/s11102-020-01099-z","DOI":"10.1007\/s11102-020-01099-z"},{"issue":"9","key":"2700_CR26","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1210\/jc.2014-2132","volume":"99","author":"E Gomes-Santos","year":"2014","unstructured":"E. Gomes-Santos, R. Salvatori, T.O. Ferr\u00e3o, C.R.P. Oliveira, R.D.C.A. Diniz, J.A.M. Santana, F.A. Pereira, R.A.A. Barbosa, A.H.O. Souza, E.V. Melo, C.C. Epit\u00e1cio-Pereira, A.A. Oliveira-Santos, I.A.S. Oliveira, J.A. Machado, F.J. Santana-J\u00fanior, J.A.S. Barreto-Filho, M.H. Aguiar-Oliveira, Increased visceral adiposity and cortisol to cortisone ratio in adults with congenital lifetime isolated GH deficiency. J. Clin. Endocrinol. Metab. 99(9), 3285\u20133289 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2700_CR27","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","volume":"17","author":"WL Holland","year":"2013","unstructured":"W.L. Holland, A.C. Adams, J.T. Brozinick, H.H. Bui, Y. Miyauchi, C.M. Kusminski, S.M. Bauer, M. Wade, E. Singhal, C.C. Cheng, K. Volk, M.-S. Kuo, R. Gordillo, A. Kharitonenkov, P.E. Scherer, An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab. 17(5), 790\u2013797 (2013)","journal-title":"Cell Metab."},{"issue":"5","key":"2700_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","volume":"17","author":"Z Lin","year":"2013","unstructured":"Z. Lin, H. Tian, K.S.L. Lam, S. Lin, R.C.L. Hoo, M. Konishi, N. Itoh, Y. Wang, S.R. Bornstein, A. Xu, X. Li, Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 17(5), 779\u2013789 (2013)","journal-title":"Cell Metab."},{"issue":"2","key":"2700_CR29","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1210\/jc.2009-1919","volume":"95","author":"CRP Oliveira","year":"2010","unstructured":"C.R.P. Oliveira, R. Salvatori, R.A. Meneguz-Moreno, M.H. Aguiar-Oliveira, R.M.C. Pereira, E.H.A. Valen\u00e7a, V.P. Araujo, N.T. Farias, D.C.R. Silveira, J.G.H. Vieira, J.A.S. Barreto-Filho, Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency. J. Clin. Endocrinol. Metab. 95(2), 693\u2013698 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2700_CR30","doi-asserted-by":"publisher","first-page":"e12822","DOI":"10.1111\/acel.12822","volume":"17","author":"J Villarroya","year":"2018","unstructured":"J. Villarroya, J.M. Gallego\u2010Escuredo, A. Delgado\u2010Angl\u00e9s, M. Cair\u00f3, R. Moure, M.G. Mateo, J.C. Domingo, P. Domingo, M. Giralt, F. Villarroya, Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue. Aging Cell 17, e12822 (2018). https:\/\/doi.org\/10.1111\/acel.12822","journal-title":"Aging Cell"},{"issue":"4","key":"2700_CR31","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cmet.2016.09.001","volume":"24","author":"SM Solon-Biet","year":"2016","unstructured":"S.M. Solon-Biet, V.,C. Cogger, T. Pulpitel, M. Heblinski, D. Wahl, A.C. McMahon, A. Warren, J. Durrant-Whyte, K.A. Walters, J.R. Krycer, F. Ponton, R. Gokarn, J.A. Wali, K. Ruohonen, A.D. Conigrave, D.E. James, D. Raubenheimer, C.D. Morrison, D.G. Le Couteur, S.J. Simpson, Defining the nutritional and metabolic context of FGF21 using the geometric framework. Cell Metab. 24(4), 555\u2013565 (2016)","journal-title":"Cell Metab."},{"key":"2700_CR32","doi-asserted-by":"publisher","unstructured":"A. Erickson, R. Moreau, The regulation of FGF21 gene expression by metabolic factors and nutrients. Horm. Mol. Biol. Clin. Invest. 30(1) (2016). https:\/\/doi.org\/10.1515\/hmbci-2016-0016","DOI":"10.1515\/hmbci-2016-0016"},{"key":"2700_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12020-015-0670-2","volume":"51","author":"AA Oliveira-Santos","year":"2016","unstructured":"A.A. Oliveira-Santos, R. Salvatori, E. Gomes-Santos, J.A.M. Santana, \u00c2.C.G.B. Leal, R.A.A. Barbosa, C.R.P. Oliveira, A.H.O. Souza, E.H.O. Valen\u00e7a, M.H. Aguiar-Oliveira, Subjects with isolated GH deficiency due to a null GHRHR mutation eat proportionally more, but healthier than controls. Endocrine 51, 317\u2013322 (2016)","journal-title":"Endocrine"},{"issue":"5","key":"2700_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1373\/clinchem.2010.155184","volume":"57","author":"H Yu","year":"2011","unstructured":"H. Yu, F. Xia, K.S.L. Lam, Y. Wang, Y. Bao, J. Zhang, Y. Gu, P. Zhou, J. Lu, W. Jia, A. Xu, Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. Clin. Chem. 57(5), 691\u2013700 (2011)","journal-title":"Clin. Chem."},{"key":"2700_CR35","doi-asserted-by":"publisher","unstructured":"I. Wolf, S. Shahmoon, M.B. Ami, Y. Levy-Shraga, K. Mazor-Aronovitch, O. Pinhas-Hamiel, Y. Yeshayahu, R. Hemi, H. Kanety, T. Rubinek, D. Modan-Moses, Association between decreased klotho blood levels and organic growth hormone deficiency in children with growth impairment. Plos One. (2014). https:\/\/doi.org\/10.1371\/journal.pone.0107174","DOI":"10.1371\/journal.pone.0107174"},{"key":"2700_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1530\/EJE-12-1045","volume":"168","author":"MC Neidert","year":"2013","unstructured":"M.C. Neidert, L. Sze, C. Zwimpfer, J. Sarnthein, B. Seifert, K. Frei, H. Leske, E.J. Rushing, C. Schmid, R.-L. Bernays, Soluble \u03b1-Klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas. Eur. Jour Endocr. 168, 575\u2013583 (2013)","journal-title":"Eur. Jour Endocr."},{"issue":"1","key":"2700_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2796.2012.02542.x","volume":"272","author":"L Sze","year":"2012","unstructured":"L. Sze, R.L. Bernays, C. Zwimpfer, P. Wiesli, M. Br\u00e4ndle, C. Schmid, Excessively high soluble Klotho in patients with acromegaly. J. Int Med 272(1), 93\u201397 (2012)","journal-title":"J. Int Med"},{"key":"2700_CR38","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s12020-019-01998-7","volume":"65","author":"CS Barros-Oliveira","year":"2019","unstructured":"C.S. Barros-Oliveira, R. Salvatori, J.S.S. Santos, P.F.C. Santos, A.A. Oliveira-Santos, C.G. Marinho, E.G. Santos, \u00c2.C.G.B. Leal, V.C. Campos, N.P. Damascena, C.R.P. Oliveira, M.H. Aguiar-Oliveira, Sweat and vitamin D status in congenital, lifetime, untreated GH deficiency. Endocrine 65, 710\u2013713 (2019)","journal-title":"Endocrine"},{"issue":"5742","key":"2700_CR39","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","volume":"309","author":"H Kurosu","year":"2005","unstructured":"H. Kurosu, M. Yamamoto, J.D. Clark, J.V. Pastor, A. Nandi, P. Gurnani, O.P. McGuinness, H. Chikuda, M. Yamaguchi, H. Kawaguchi, I. Shimomura, Y. Takayama, J. Herz, C.R. Kahn, K.P. Rosenblatt, M. Kuro-o, Suppression of aging in mice by the hormone Klotho. Science 309(5742), 1829\u20131833 (2005)","journal-title":"Science"},{"key":"2700_CR40","doi-asserted-by":"publisher","unstructured":"Y. Zhang, Y. Xie, E.D. Berglund, K.C. Coate, T.T. He, T. Katafuchi, G. Xiao, M.J. Potthoff, W. Wei, Y. Wan, R.T. Yu, R.M. Evans, S.A. Kliewer, D.J. Mangelsdorf, The starvation hormone, fibroblast growth factor-21, extends lifespan in mice. eLife (2012). https:\/\/doi.org\/10.7554\/eLife.00065","DOI":"10.7554\/eLife.00065"},{"issue":"2","key":"2700_CR41","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1073\/pnas.022484299","volume":"99","author":"DE Arking","year":"2002","unstructured":"D.E. Arking, A. Krebsova, M. Macek Sr., M. Macek Jr., A. Arking, I.S. Mian, L. Fried, A. Hamosh, S. Dey, I. McIntosh, H.C: Dietz, Association of human aging with a functional variant of klotho. Proc. Natl Acad. Sci. USA 99(2), 856\u2013861 (2002)","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"1","key":"2700_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2265.2006.02558.x","volume":"65","author":"Z Laron","year":"2006","unstructured":"Z. Laron, S. Ginsberg, P. Lilos, M. Arbiv, N. Vaisman, Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin. Endocrinol. (Oxf.) 65(1), 114\u2013117 (2006)","journal-title":"Clin. Endocrinol. (Oxf.)"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-021-02700-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02700-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T17:26:49Z","timestamp":1623950809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-021-02700-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02700-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"type":"print","value":"1355-008X"},{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2021,3,26]]},"assertion":[{"value":"22 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"R. Salvatori serves on Novordisk advisory board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}